Time course of ovarian tumour growth in soft agar culture.

por Verheijen, R. H., Feitz, W. F., Kenemans, P., Vooys, G. P., Herman, C. J.
Publicado 1985

Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area

por Bulk, S, Visser, O, Rozendaal, L, Verheijen, R H M, Meijer, C J L M
Publicado 2003

From open radical hysterectomy to robot-assisted laparoscopic radical hysterectomy for early stage cervical cancer: aspects of a single institution learning curve

por Schreuder, H. W. R., Zweemer, R. P., van Baal, W. M., van de Lande, J., Dijkstra, J. C., Verheijen, R. H. M.
Publicado 2010

Does Probability Guided Hysteroscopy Reduce Costs in Women Investigated for Postmenopausal Bleeding?

por Breijer, M. C., van Hanegem, N., Visser, N. C. M., Verheijen, R. H. M., Mol, B. W. J., Pijnenborg, J. M. A., Opmeer, B. C., Timmermans, A.
Publicado 2015

Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia

por Nobbenhuis, M A E, Meijer, C J L M, Brule, A J C van den, Rozendaal, L, Voorhorst, F J, Risse, E K J, Verheijen, R H M, Helmerhorst, T J M
Publicado 2001

Proton MRS of cervical cancer at 7 T

por Arteaga de Castro, C.S., Hoogendam, J.P., van Kalleveen, I.M.L., Raaijmakers, A.J.E., Zweemer, R.P., Verheijen, R.H.M., Luijten, P.R., Veldhuis, W.B., Klomp, D.W.J.
Publicado 2018

Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test

por Rijkaart, D C, Coupe, V M H, van Kemenade, F J, Heideman, D A M, Hesselink, A T, Verweij, W, Rozendaal, L, Verheijen, R H, Snijders, P J, Berkhof, J, Meijer, C J L M
Publicado 2010

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications

por Rijkaart, D C, Berkhof, J, van Kemenade, F J, Coupe, V M H, Rozendaal, L, Heideman, D A M, Verheijen, R H M, Bulk, S, Verweij, W, Snijders, P J F, Meijer, C J L M
Publicado 2012

A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings

por Jacobs, M V, Walboomers, J M M, Beek, J van, Voorhorst, F J, Verheijen, R H M, Meijer, C J L M, Brule, A J C van den, Helmerhorst, ThJ M, Snijders, P J F
Publicado 1999

Expression of CD3-ζ on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes

por de Gruijl, T D, Bontkes, H J, Peccatori, F, Gallee, M P W, Helmerhorst, Th J M, Verheijen, R H M, Aarbiou, J, Mulder, W M C, Walboomers, J M M, Meijer, C J L M, van de Vange, N, Scheper, R J
Publicado 1999

No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study

por Hermsen, B B J, Olivier, R I, Verheijen, R H M, van Beurden, M, de Hullu, J A, Massuger, L F, Burger, C W, Brekelmans, C T, Mourits, M J, de Bock, G H, Gaarenstroom, K N, van Boven, H H, Mooij, T M, Rookus, M A
Publicado 2007